Oxford BioMedica PLC
Save
197.12M
Market cap
–
Current P/E
250.00x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes.
Similar securities
Based on sector and market capitalization
Report issue